BackCalliditas Therapeutics AB Overview

Calliditas Therapeutics AB Current Cash

Calliditas Therapeutics AB's current cash is $800M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$797.28M
↓ 7.95% YoYΔ $-68.90M vs prior year quarter

Peer trimmed avg / median

Loading

Calliditas Therapeutics AB Current Cash History

Loading

Calliditas Therapeutics AB vs. peers: Current Cash Comparison

Loading

Calliditas Therapeutics AB Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Calliditas Therapeutics AB (CALT) FAQ

Calliditas Therapeutics AB (CALT) currently reports a current cash of $800M as of June 2024. That compares with $870M in the prior-year period — down 8.0% year over year. Use the charts on this page to explore Calliditas Therapeutics AB's current cash history and peer comparisons.

Calliditas Therapeutics AB's current cash decreased from $870M to $800M — a 8.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calliditas Therapeutics AB reported $800M in current cash as of June 2024. That compares with $870M in the prior-year period — down 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $800M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calliditas Therapeutics AB, and consider following CALT for alerts when major investors trade the stock.

Calliditas Therapeutics AB is classified in the Healthcare sector. On current cash, it currently shows $800M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALT with unrelated industries.